Status Tags: Clearance; Mitigation; Withdraw and Refiled (2d Time); Interim Order; Withdrawn and Refiled Acquirer: Sino Biopharmaceutical Limited (Hong Kong SAR, China) Acquired: F-Star Therapeutics, Inc. (United Kingdom; U.S.) Value: $161 million Industry Tags: Pharmaceutical; Biotechnology; Healthcare… Continue Reading
Status: No Action Acquirer: Novartis AG (Switzerland) Acquired: Endocyte, Inc. (U.S.) Value: $2.1 billion Industry Tags: Health Care; Pharmaceutical; Biotechnology… Continue Reading
UPDATE: BIS is extending the public comments deadline on emerging technology export controls from December 19 this year to January 10, 2019, per an unpublished Federal Register notice released on December 13. The proposed rule will officially appear in the Federal Register on December 14. Posted on November 26, 2018 On November 19, 2018, the US … Continue Reading